logo

For the Inventor, By the Inventor

Milan, Italy

Alessandro Pontiroli

This inventor holds 24 USPTO granted patents, plus 3 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Sicor Inc., Indena S.p.a.. Active years: 2003-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alessandro Pontiroli. Retrieved from https://idiyas.com/inventor/alessandro-pontiroli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 91.7



Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Maria della Versa, IT (2010)
  • S. Maria della Versa, IT (2010 - 2014)
  • Milan, IT (2003 - 2017)

Company Filing History:

goldMedal14 out of 26 
 
Sicor Inc.
 patents
silverMedal10 out of 216 
 
Indena S.p.a.
 patents

Years Active: 2003-2017

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pemetrexed Diacid
Tiotropium Bromide
Taxane Derivatives
Anticancer Drugs
Pharmaceutical Salts
Lyophilization
Baccatin III
Semi-Synthetic Taxanes
Antiangiogenetic Activities
Pharmaceutical Compositions
Condensation Derivatives
N-Deacetylthiocolchicine
24 patents (USPTO):Explore Patents
1. 9718829 - Crystalline forms of pemetrexed diacid and processes for the preparation thereof (2017-08-01),
2. 9562050 - Crystalline forms of pemetrexed diacid and processes for the preparation thereof (2017-02-07),
3. 9156841 - Crystalline forms of pemetrexed diacid and processes for the preparation thereof (2015-10-13),
4. 9108962 - Forms of tiotropium bromide and processes for preparation thereof (2015-08-18),
5. 8846926 - Forms of tiotropium bromide and processes for preparation thereof (2014-09-30),
6. 8629152 - Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid (2014-01-14),
7. 8378103 - Process for the preparation of tiotropium bromide (2013-02-19),
8. 8362245 - Processes for preparing intermediates of pemetrexed (2013-01-29),
9. 8344143 - Process for the preparation of tiotropium bromide (2013-01-01),
10. 8163913 - Forms of tiotropium bromide and processes for preparation thereof (2012-04-24),
11. 8088919 - Crystalline forms of pemetrexed diacid and processes for the preparation thereof (2012-01-03),
12. 7994180 - Processes for preparing intermediates of pemetrexed (2011-08-09),
13. 7692025 - Process for the preparation of anticancer drugs (2010-04-06),
14. 7662963 - Process for the preparation of tiotropium bromide (2010-02-16),
15. RE40901 - Taxane derivatives and processes for the preparation thereof (2009-08-31),

Title: Alessandro Pontiroli - Innovative Inventor from Milan

Introduction: Alessandro Pontiroli is a renowned inventor hailing from Milan, Italy, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Alessandro Pontiroli holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Pontiroli has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Alessandro Pontiroli has collaborated with top universities, research institutions, and multinational corporations to bring his innovative ideas to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Alessandro Pontiroli's passion for innovation and his relentless pursuit of excellence have established him as a visionary inventor in the global technology landscape, with a legacy that continues to inspire future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…